Table 5. Odds ratio of HbA1c for incidence of hyperuricemia, and stepwise logistic regression for hyperuricemia.
Population [N (%)] | Odds ratio | 95% CI | P-value |
---|---|---|---|
T2DM subjects [388 (17.24%)] | |||
Model1a | 0.886 | 0.825~0.952 | 0.001 |
Model2b | 0.897 | 0.833~0.965 | 0.003 |
Model3c | 0.988 | 0.981~0.995 | 0.001 |
Physical examination population | |||
Normal glucose [556 (15.67%)] | |||
Model4a | 1.352 | 1.101~1.662 | 0.004 |
Model5b | 1.229 | 0.974~1.551 | 0.082 |
Model6d | 1.030 | 0.786~1.350 | 0.828 |
T2DM subjects [160 (18.37%)] | |||
Model7a | 0.626 | 0.434~0.902 | 0.012 |
Model8b | 0.650 | 0.462~0.914 | 0.013 |
Model9e | 0.722 | 0.539~0.968 | 0.029 |
*P < 0.05 was considered statistically significant.
aUnadjusted baseline values of HbA1c.
bAdjusted for age and sex.
cFurther adjusted for duration of diabetes, BMI, SBP, AST, eGFR, BUN, SCR, TG, TC, VLDL, FINS, P2INS, HOMA-IR. (see Table 1 for abbreviations).
dFurther adjusted for eGFR, BMI, SBP, DBP, BUN, SCR, FBG, TG, HDL.
eFurther adjusted for eGFR, BMI, BUN, SCR, FBG, TG.